US drugmaker Pfizer announced on Wednesday morning statement that it will supply the United States with 100 million additional doses of its COVID-19 vaccine by July 2021. The deal brings the total number of doses to be delivered to the country to 200 million, allowing for 100 million people to be vaccinated.
Chinese pharmaceutical firm SinoVac will be sending its second shipment to Brazil, state media reported on Wednesday.
UK’s AstraZeneca announced on Sunday it had agreed to buy US drugmaker Alexion Pharmaceuticals for $39 billion in its largest-ever deal, diversifying away from its cancer business in a bet on immunology and rare-disease drugs.
GlaxoSmithKline and Sanofi announced on Friday morning that clinical trials of their COVID-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year.
AvKARE or Pulaski, TN is voluntarily recalling one lot of erectile dysfunction drug Sildenafil 100 mg tablets and one lot of anti-depressant Trazodone 100mg tablets to the consumer level after the two got mixed up during bottling at a third-party plant.
The Brazilian government is currently in advanced talks with pharmaceutical giant Pfizer to buy 70 million doses of its COVID-19 vaccine and a Memorandum of Intent could be signed later this week.
The UK government has approved the Pfizer-BioNTech vaccine and said that it would be rolled out by Dec. 7.
The US government agreed on Thursday morning to loan privately-held biotechnology company Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that could help address future pandemics.
Purdue Pharma pleaded guilty to criminal charges over the handling of its prescription painkiller OxyContin on Tuesday afternoon, capping a deal with federal prosecutors to resolve a probe into the company’s role in the US opioid crisis.
The European Union has made a deal with Moderna, a biotech firm from the United States, for the supply of up to 160 million doses of the COVID-19 vaccine.